All In MedTech

FDA Clearance Tracker · P890014-S008

ETI-HA-IGMK PLUS KIT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 14, 2005 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P890014-S008
Device name
ETI-HA-IGMK PLUS KIT
Applicant location
Stillwater, MN
Received
Jul 20, 2005
Decided
Dec 14, 2005
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P890014

Device type

Device class
Class II
Regulation
21 CFR 866.3310

Every decision under product code LOL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR CHANGE TO THE ASSAY CUTOFF CALCULATION THAT IS DESIGNED TO REDUCE THE NUMBER OF LOW LEVEL, NON-CLINICALLY RELEVANT POSITIVE RESULTS REPORTED BY THE ETI-HA-IGMK PLUS ASSAY.

Source documents

Other decisions for DiaSorin, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.